Human stem cells successfully treat multiple sclerosis in mice
Steve Connor is the Science Editor of The Independent and i. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; four times highly commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigations into the tobacco industry. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 05 June 2014
Human stem cells have been used successfully to treat multiple sclerosis in mice. The treated mice were able to walk and run around normally while untreated animals continued to be paralysed by the disease, scientists said.
The researchers believe the findings are promising enough to move to clinical trials on patients in the hope of developing effective treatments for this incurable and progressively debilitating disorder of the nervous system, which affects about 100,000 people in the UK.
The study involved injections of stem cells derived from human embryos, which were compared with stem cells from adult bone marrow, which are already being used in clinical trials for the treatment of multiple sclerosis. The embryonic stem cells significantly outperformed the bone marrow stem cells, scientists said.
The research was led by Xiaofang Wang from ImStem Biotechnology, based in Farmington, Connecticut, who said it was a surprise that the stem cells derived from adult bone marrow performed so badly in comparison to the embryonic stem cells.
Multiple sclerosis is caused by the destruction of the outer fatty, myelin sheath that surrounds and insulates individual nerve cells. The injected stem cells appear to stop the damage and help to restore nerve function, the researchers said.
The stem cells used in the study, published in the journal Stem Cell Reports, belong to a class known as mesenchymal stem cells, which normally form the tissues of the brain and spinal cord.
“Although there is currently no cure for MS, we are excited about the unique anti-disease abilities of these cells and feel that they may be well suited for the clinical treatment of multiple sclerosis,” said Robert Lanza, chief scientific officer of the Advanced Cell Technology, a Massachusetts-based biotechnology firm who collaborated in the study.
“The cells not only reduced the clinical symptoms of multiple sclerosis but prevented demyelination, which disrupts the ability of the nervous system to communicate, resulting in a wide range of symptoms in patients, including blurred vision, loss of balance, slurred speech, tremors, numbness, extreme fatigue, paralysis and blindness,” Dr Lanza said.
- 1 Woman 'suffocates newborn baby in plastic bag and puts it in her desk minutes after giving birth'
- 3 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
- 5 Chinese student carries disabled friend to school every day for three years
Nepal earthquake in pictures: Photos show devastation caused by 7.8 magnitude earthquake
Royal baby: Live updates as superbug closes ward at St Mary's Hospital in London where Duchess of Cambridge is due to give birth
Nepal earthquake: Rescuers forced to dig with their bare hands in search for survivors as images show damage to historic buildings
Ed Miliband and Boris Johnson in angry clash live on BBC's Andrew Marr Show
Bali Nine executions: British grandmother on death row in Indonesia Lindsay Sandiford says she 'just wants to get it over with'
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband
The sickening truth about food banks that the Tories don't want you to know
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
General Election 2015: Britain would become a 'communist dictatorship' under Ed Miliband and Nicola Sturgeon, claims wife of Michael Gove
£26000 - £28000 per annum + benefits : Ashdown Group: Senior Accounts Assistan...
£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...
£22000 - £40000 per annum: Recruitment Genius: This company is part of a Group...
£16000 - £18000 per annum: Recruitment Genius: Are you a a young, dynamic pers...